Calithera Biosciences Balance Sheet - Annual (NASDAQ:CALA)

Add to My Stocks
$4.75 $0.05 (1.04%) CALA stock closing price Sep 18, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Calithera Biosciences, and helps in stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Calithera Biosciences stock analysis. Annual results are typically accompanied with the company releasing financial statements. Calithera Biosciences had a long term debt of $- at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Calithera Biosciences operating cash flow and Calithera Biosciences revenue also. Calithera Biosciences debt to equity ratio is 0.

View latest 10 year balance sheet data to check Calithera Biosciences financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash48.47M10.6M6.1M101.96M33.82M2.2M
Marketable Securities115.31M41.18M63.82M---
Receivables1.14M-----
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets2.73M1.78M2.56M1.89M--
Total Current Assets
167.66M53.56M72.49M103.86M34.16M2.27M
Property Plant & Equipment3.99M2.78M2.52M2.09M1.43M1.29M
Accumulated Depreciation2.24M1.88M1.59M1.23M--
Net Property Plant & Equipment
1.75M-----
Investment & Advances22.36M-1.99M---
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets------
Total Assets
192.45M54.79M75.75M104.77M34.84M3.06M
Notes Payable------
Accounts Payable1.07M-----
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses8.93M4.05M3.27M3.42M1.19M-
Income Taxes Payable------
Other Current Liabilities29.01M-----
Total Current Liabilities
39.02M4.45M3.83M4.12M1.34M-
Mortgages------
Deferred Taxes/Income3.12M-----
Convertible Debt------
Long-Term Debt------
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
42.14M4.89M3.96M4.4M1.37M-
Minority Interest------
Preferred Stock----54.28M10.72M
Common Stock Net------
Capital Surplus300.9M172.41M156.35M152.21M9.32M9.19M
Retained Earnings-150.33M-122.5M-84.49M-51.85M-30.14M-17.76M
Treasury Stock------
Other Liabilities-0.27M-0.01M-0.06M---
Shareholders Equity150.3M49.9M71.78M100.36M33.46M-8.57M
Total Liabilities & Shareholders Equity192.45M54.79M75.75M104.77M34.84M3.06M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Calithera Biosciences stock price, and Calithera Biosciences historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Calithera Biosciences PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: CALA total assets, which was at $192.45M for 2017 is a balance sheet item representing value of what Calithera Biosciences owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. CALA stock had total liabilities of $42.14M for the year 2017.

Calithera Biosciences Balance Sheet - Key Ratios

Current ratio
13.66
Debt to equity ratio
0
Asset turnover ratio
0.41
Receivables turnover
18.49
Price to book ratio
1.11